Improving the dissolution of a water-insoluble orphan drug through a fused deposition modelling 3-Dimensional printing technology approach-Reference-Cited by-同舟云学术

Improving the dissolution of a water-insoluble orphan drug through a fused deposition modelling 3-Dimensional printing technology approach

Published:2020-09 Issue: Volume:152 Page:105426
ISSN:0928-0987
Container-title:European Journal of Pharmaceutical Sciences
language:en
Short-container-title:European Journal of Pharmaceutical Sciences

Author:

SAYDAM Mehtap,TAKKA Sevgi

Publisher

Elsevier BV

Subject

Pharmaceutical Science

Reference67 articles.

1. Affinisol HPMC HME for Hot Melt Extrusion, 2020. Dow Pharma.

2. Emergence of 3D Printed Dosage Forms: opportunities and Challenges;Alhnan;Pharm. Res.,2016

3. Stochiometrically governed molecular interactions in drug: poloxamer solid dispersions;Ali;Int. J. Pharm.,2010

4. Solubilization of drugs using sodium lauryl sulfate: experimental data and modeling, J;Alizadeh;Mol. Liq.,2018

5. New stability indicating liquid chromatographic method for the quantitative determination of Rufinamide in presence of degredant products;Annapurna;Drug Invent. Today,2012

Cited by 34 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Regulations on excipients used in 3D printing of pediatric oral forms;International Journal of Pharmaceutics;2024-09

2. THETA as an Efficient Cu-Binding Ligand for Manual and Automated “Click” Synthesis: the Rufinamide Case;Organic Process Research & Development;2024-07-15

3. Pediatric Formulations Developed by Extrusion-Based 3D Printing: From Past Discoveries to Future Prospects;Pharmaceutics;2024-03-22

4. Application of 3D printing in early phase development of pharmaceutical solid dosage forms;International Journal of Pharmaceutics;2024-03

5. Excipients in Pharmaceutical Additive Manufacturing: A Comprehensive Exploration of Polymeric Material Selection for Enhanced 3D Printing;Pharmaceutics;2024-02-24